ACQI researchers are very grateful to receive an injection of support from the RPH (Royal Perth Hospital) Imaging Research Fund. The Round #3 Research Grant will provide $79,766 to support a new study into the use of amide proton transfer magnetic resonance imaging (APT MRI) for characterising the extent and nature of glioblastoma, and for predicting the outcomes of treatment for this disease that is prevalent amongst younger adults and typically provides a poor prognosis. The grant will drive a study of patients presenting to the Neurological Intervention & Imaging Service of Western Australia at Sir Charles Gairdner Hospital, allowing the analysis of images acquired before, during and after treatment. The imaging information will be combined with pathology and treatment data to create predictive models using machine learning with the aim to be able to accurately predict the outcome before the disease can again progress. This will provide clinicians with the opportunity to engage in new treatment strategies earlier, or to avoid new treatments that may hinder a patient’s quality of life but not actually be necessary for treating their disease.